p.89 抽出テキスト

registry. JACC Cardiovasc Interv 2021;14:1978–91. https://doi.org/10.1016/j.jcin.2021. 07.015 445. Bowdish ME, Habib RH, Kaneko T, Thourani VH, Badhwar V. Cardiac surgery after transcatheter aortic valve replacement: trends and outcomes. Ann Thorac Surg 2024; 118:155–62. https://doi.org/10.1016/j.athoracsur.2024.03.024 446. Landes U, Webb JG, De Backer O, Sondergaard L, Abdel-Wahab M, Crusius L, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol 2020;75:1882–93. https://doi.org/10.1016/j.jacc.2020.02.051 447. Tam DY, Dharma C, Rocha RV, Ouzounian M, Wijeysundera HC, Austin PC, et al. Transcatheter ViV versus redo surgical AVR for the management of failed biological prosthesis: early and late outcomes in a propensity-matched cohort. JACC Cardiovasc Interv 2020;13:765–74. https://doi.org/10.1016/j.jcin.2019.10.030 448. Sá MBPO, Van den Eynde J, Simonato M, Cavalcanti LRP, Doulamis IP, Weixler V, et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: an updated meta-analysis. JACC Cardiovasc Interv 2021;14:211–20. https:// doi.org/10.1016/j.jcin.2020.10.020 449. Percy ED, Harloff MT, Hirji S, McGurk S, Yazdchi F, Newell P, et al. Nationally representative repeat transcatheter aortic valve replacement outcomes: report from the centers for Medicare and Medicaid services. JACC Cardiovasc Interv 2021;14: 1717–26. https://doi.org/10.1016/j.jcin.2021.06.011 450. Makkar RR, Kapadia S, Chakravarty T, Cubeddu RJ, Kaneko T, Mahoney P, et al. Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study. Lancet 2023;402:1529–40. https://doi.org/10.1016/s0140- 6736(23)01636-7 451. Deharo P, Bisson A, Herbert J, Lacour T, Etienne CS, Porto A, et al. Transcatheter valve-in-valve aortic valve replacement as an alternative to surgical re-replacement. J Am Coll Cardiol 2020;76:489–99. https://doi.org/10.1016/j.jacc.2020.06.010 452. Dismorr M, Glaser N, Franco-Cereceda A, Sartipy U. Effect of prosthesis-patient mismatch on long-term clinical outcomes after bioprosthetic aortic valve replacement. J Am Coll Cardiol 2023;81:964–75. https://doi.org/10.1016/j.jacc.2022.12.023 453. Head SJ, Mokhles MM, Osnabrugge RL, Pibarot P, Mack MJ, Takkenberg JJ, et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J 2012;33:1518–29. https://doi.org/ 10.1093/eurheartj/ehs003 454. Herrmann HC, Daneshvar SA, Fonarow GC, Stebbins A, Vemulapalli S, Desai ND, et al. Prosthesis–patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS/ACC TVT registry. J Am Coll Cardiol 2018;72:2701–11. https://doi.org/10.1016/j.jacc.2018.09.001 455. Ternacle J, Pibarot P, Herrmann HC, Kodali S, Leipsic J, Blanke P, et al. Prosthesis-patient mismatch after aortic valve replacement in the PARTNER 2 trial and registry. JACC Cardiovasc Interv 2021;14:1466–77. https://doi.org/10.1016/j.jcin. 2021.03.069 456. Akodad M, Sellers S, Landes U, Meier D, Tang Gilbert HL, Gada H, et al. Balloon-expandable valve for treatment of Evolut valve failure. JACC Cardiovasc Interv 2022;15:368–77. https://doi.org/10.1016/j.jcin.2021.12.021 457. Ribeiro HB, Rodés-Cabau J, Blanke P, Leipsic J, Kwan Park J, Bapat V, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J 2018;39:687–95. https://doi.org/10.1093/eurheartj/ehx455 458. Ochiai T, Oakley L, Sekhon N, Komatsu I, Flint N, Kaewkes D, et al. Risk of coronary obstruction due to sinus sequestration in redo transcatheter aortic valve replacement. JACC Cardiovasc Interv 2020;13:2617–27. https://doi.org/10.1016/j.jcin.2020.09.022 459. Akodad M, Sellers S, Gulsin GS, Tzimas G, Landes U, Chatfield Andrew G, et al. Leaflet and neoskirt height in transcatheter heart valves. JACC Cardiovasc Interv 2021;14: 2298–300. https://doi.org/10.1016/j.jcin.2021.07.034 460. Tang GH, Spencer J, Rogers T, Grubb KJ, Gleason P, Gada H, et al. Feasibility of coronary access following redo-TAVR for Evolut failure: a computed tomography simulation study. Circ Cardiovasc Interv 2023;16:e013238. https://doi.org/10.1161/ CIRCINTERVENTIONS.123.013238 461. De Backer O, Landes U, Fuchs A, Yoon SH, Mathiassen ON, Sedaghat A, et al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography. JACC Cardiovasc Interv 2020;13:2528–38. https://doi.org/10.1016/j.jcin.2020. 06.016 462. Fukui M, Okada A, Thao KR, Burns MR, Koike H, Wang C, et al. Feasibility of redotranscatheter aortic valve replacement in Sapien valves based on in vivo computed tomography assessment. Circ Cardiovasc Interv 2023;16:e013497. https://doi.org/10. 1161/CIRCINTERVENTIONS.123.013497 463. Chhatriwalla AK, Allen KB, Depta JP, Rodriguez E, Thourani VH, Whisenant BK, et al. Outcomes of bioprosthetic valve fracture in patients undergoing valve-in-valve TAVR. JACC Cardiovasc Interv 2023;16:530–9. https://doi.org/10.1016/j.jcin.2022.12.019 464. Khan JM, Babaliaros VC, Greenbaum AB, Spies C, Daniels D, Depta JP, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: results from the multicenter international BASILICA registry. JACC Cardiovasc Interv 2021;14:941–8. https://doi.org/10.1016/j.jcin.2021.02.035 465. Jørgensen TH, Thyregod HGH, Ihlemann N, Nissen H, Petursson P, Kjeldsen BJ, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021;42: 2912–9. https://doi.org/10.1093/eurheartj/ehab375 466. O’Hair D, Yakubov SJ, Grubb KJ, Oh JK, Ito S, Deeb GM, et al. Structural valve deterioration after self-expanding transcatheter or surgical aortic valve implantation in patients at intermediate or high risk. JAMA Cardiol 2023;8:111–9. https://doi.org/10. 1001/jamacardio.2022.4627 467. Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodés-Cabau J. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol 2017;70:1013–28. https://doi.org/ 10.1016/j.jacc.2017.07.715 468. Pibarot P, Magne J, Leipsic J, Cote N, Blanke P, Thourani VH, et al. Imaging for predicting and assessing prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging 2019;12:149–62. https://doi.org/10.1016/j.jcmg.2018.10.020 469. Freitas-Ferraz Afonso B, Tirado-Conte G, Dagenais F, Ruel M, Al-Atassi T, Dumont E, et al. Aortic stenosis and small aortic annulus. Circulation 2019;139:2685–702. https:// doi.org/10.1161/CIRCULATIONAHA.118.038408 470. Tang GHL, Zaid S, Fuchs A, Yamabe T, Yazdchi F, Gupta E, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv 2020;13:1030–42. https://doi. org/10.1016/j.jcin.2020.02.005 471. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-Year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2485–91. https://doi.org/10.1016/S0140-6736(15)60290-2 472. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696–704. https://doi.org/10.1056/NEJMoa1202277 473. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J 1987;8:471–83. https://doi.org/10.1093/oxfordjournals.eurheartj. a062307 474. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990;15: 1012–7. https://doi.org/10.1016/0735-1097(90)90234-g 475. Mangner N, Stachel G, Woitek F, Haussig S, Schlotter F, Hollriegel R, et al. Predictors of mortality and symptomatic outcome of patients with low-flow severe aortic stenosis undergoing transcatheter aortic valve replacement. J Am Heart Assoc 2018;7:e007977. https://doi.org/10.1161/JAHA.117.007977 476. Eleid MF, Padang R, Al-Hijji M, Pislaru SV, Greason KL, Maltais S, et al. Hemodynamic response in low-flow low-gradient aortic stenosis with preserved ejection fraction after TAVR. J Am Coll Cardiol 2019;73:1731–2. https://doi.org/10.1016/j.jacc.2019.01. 034 477. Rusinaru D, Bohbot Y, Ringle A, Marechaux S, Diouf M, Tribouilloy C. Impact of low stroke volume on mortality in patients with severe aortic stenosis and preserved left ventricular ejection fraction. Eur Heart J 2018;39:1992–9. https://doi.org/10.1093/ eurheartj/ehy123 478. Zheng Q, Djohan AH, Lim E, Ding ZP, Ling LH, Shi L, et al. Effects of aortic valve replacement on severe aortic stenosis and preserved systolic function: systematic review and network meta-analysis. Sci Rep 2017;7:5092. https://doi.org/10.1038/s41598-017- 05021-9 479. Salaun E, Clavel MA, Hahn RT, Jaber WA, Asch FM, Rodriguez L, et al. Outcome of flow-gradient patterns of aortic stenosis after aortic valve replacement: an analysis of the PARTNER 2 trial and registry. Circ Cardiovasc Interv 2020;13:e008792. https:// doi.org/10.1161/CIRCINTERVENTIONS.119.008792 480. Annabi MS, Côté N, Dahou A, Bartko PE, Bergler-Klein J, Burwash IG, et al. Comparison of early surgical or transcatheter aortic valve replacement versus conservative management in low-flow, low-gradient aortic stenosis using inverse probability of treatment weighting: results from the TOPAS prospective observational cohort study. J Am Heart Assoc 2020;9:e017870. https://doi.org/10.1161/jaha.120.017870 481. Mosleh W, Amer MR, Ding Y, Megaly M, Mather JF, McMahon S, et al. Benefit of transcatheter aortic valve replacement in patients with paradoxical low-flow low-gradient versus high-gradient aortic stenosis and preserved left ventricular function. Circ Cardiovasc Interv 2021;14:e010042. https://doi.org/10.1161/circinterventions.120. 010042 482. Bohbot Y, Kowalski C, Rusinaru D, Ringle A, Marechaux S, Tribouilloy C. Impact of mean transaortic pressure gradient on long-term outcome in patients with severe aortic stenosis and preserved left ventricular ejection fraction. J Am Heart Assoc 2017;6: e005850. https://doi.org/10.1161/JAHA.117.005850 483. Costa GNF, Cardoso JFL, Oliveiros B, Gonçalves L, Teixeira R. Early surgical intervention versus conservative management of asymptomatic severe aortic stenosis: a systematic review and meta-analysis. Heart 2023;109:314–21. https://doi.org/10.1136/ heartjnl-2022-321411 484. Bohbot Y, Rusinaru D, Delpierre Q, Marechaux S, Tribouilloy C. Risk stratification of severe aortic stenosis with preserved left ventricular ejection fraction using peak aortic

ESC Guidelines                                                                                                                                                                                          4723

Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026